(Q37942538)

25 August 2017

title

Reverse transcriptase genotypes in pediatric patients failing initial antiretroviral therapy in Gaborone, Botswana (English)

1 reference

25 August 2017

0 references

0 references

anti-retroviral agent

0 references

author name string

Michael Tolle

1

1 reference

25 August 2017

Leigh Howard

2

1 reference

25 August 2017

Brianna Kirk

3

1 reference

25 August 2017

Andres Gomila

4

1 reference

25 August 2017

Heidi Schwarzwald

5

1 reference

25 August 2017

Gabriel Anabwani

6

1 reference

25 August 2017

publication date

4 October 2011

1 reference

Journal of the International Association of Providers of AIDS Care

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

260-268

1 reference

Prevalence of primary drug resistance-associated mutations among HIV type 1 vertically Infected children in Belo Horizonte, Brazil

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Diversity and prevalence of antiretroviral genotypic resistance mutations among HIV-1-infected children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Distinct resistance mutation and polymorphism acquisition in HIV-1 protease of subtypes B and F1 from children and adult patients under virological failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Antiretroviral drug resistance among HIV-1 infected children failing treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Molecular characterization of non-subtype C and recombinant HIV-1 viruses from Cape Town, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Sequencing of antiretroviral therapy in children in low- and middle-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Predicted susceptibility of etravirine in HIV patients experiencing virological failure secondary to non-nucleoside reverse transcriptase inhibitor resistance in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Detection of low-level K65R variants in nucleoside reverse transcriptase inhibitor-naive chronic and acute HIV-1 subtype C infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1545109711422273

21 January 2018

Identifiers

DOI

10.1177/1545109711422273

1 reference

25 August 2017

1 reference